Fieldfisher advises Honest Health on sale to Hims & Hers Health | Fieldfisher
Skip to main content
Press Release

Fieldfisher advises Honest Health on sale to Hims & Hers Health



United Kingdom

The acquisition marks the first Founders Factory portfolio company Fieldfisher's venture capital team has seen through from seed financing to exit.
European law firm Fieldfisher has advised the selling shareholders of London-based Honest Health on the sale of the company to Hims & Hers Health Inc, a San Francisco-headquartered, NYSE-listed multi-speciality telehealth platform focused on providing modern personalised health and wellness experiences to consumers.
The acquisition of Honest Health will further support Hims & Hers in its mission of making personalised health available to everyone, lay the foundation for future expansion into the UK and Europe and add best in class distribution capabilities, including pharmaceutical compounding.
Honest Health, founded by Sam Gluck and Pavlo Maherovsky, launched in November 2018 with Freshman, its next generation hair loss virtual clinic for men. The company has built a vertical health platform that delivers targeted care at scale for consumers under-served by public health systems and existing private clinics.
Fieldfisher first advised the company on its seed venture capital financing in November 2019 from VGC Partners and angel investors, via the firm's relationship with Founders Factory, Europe's pre-eminent tech accelerator, of which Honest Health was a portfolio company.
Commenting on the deal, Fieldfisher corporate partner Tom Ward who has led the team advising Honest Health since 2019, said:
"It has been really rewarding for the team to have helped Honest Health and the founders from their first investment through to exit.
"We wish Pavlo and Sam and the team at Hims & Hers all the best as they continue to scale the platform.
Honest Health Co-founder Sam Gluck said:
"Since launching Honest Health in the UK two and a half years ago, we have been dedicated to demolishing the obstacles standing between people and better health.
"We are excited to join the Hims & Hers team to take this mission of healthcare access and personalisation for all to the next level."
Honest Health Co-founder Pavlo Maherovsky added:
"Tom, Andy, and the wider Fieldfisher team have been instrumental to the success of Honest Health over the years.
"From advising us before our seed round, to arranging our first capital raise, and supporting us throughout our acquisition, we have always felt that we are no more than one email or phone call away from outstanding legal counsel.”
Tom was assisted on the transaction by corporate solicitor Andy Oliver and tax partner Andrew Loan.
About Fieldfisher
Fieldfisher is a European law firm with market leading practices in many of the world's most dynamic sectors.
We are an exciting, forward-thinking organisation with a particular focus on energy & natural resources, technology, finance & financial services, life sciences and media.
Our cross-border corporate group is immersed in the international M&A, private equity and venture capital market, from seed stage and growth capital financings to leveraged buy-outs and exits. Our teams provide integrated support across Europe and in each of our domestic markets.
Our network has more than 1,700 people working across 25 offices providing highly commercial advice based on an in-depth understanding of our clients' needs.
We operate across our offices in Amsterdam, Barcelona, Beijing, Belfast, Birmingham, Bologna, Brussels, Dublin, Düsseldorf, Frankfurt, Guangzhou, Hamburg, London, Luxembourg, Madrid, Manchester, Milan, Munich, Paris, Rome, Shanghai, Turin, Venice and Silicon Valley.

Sign up to our email digest

Click to subscribe or manage your email preferences.


Areas of Expertise

Private Equity

Related Work Areas

Life Sciences